OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preventing Olanzapine-Induced Weight Gain Using Betahistine: A Study in a Rat Model with Chronic Olanzapine Treatment
Jiamei Lian, Xu‐Feng Huang, Nagesh Pai, et al.
PLoS ONE (2014) Vol. 9, Iss. 8, pp. e104160-e104160
Open Access | Times Cited: 67

Showing 26-50 of 67 citing articles:

Effect of Betahistine and Metformin on Antipsychotic-Induced Weight Gain: An Analysis of Two Clinical Trials
Dongyu Kang, Zhihui Jing, Ranran Li, et al.
Frontiers in Psychiatry (2018) Vol. 9
Open Access | Times Cited: 19

Metformin reverses the schizophrenia-like behaviors induced by MK-801 in rats
Xu Wang, Chao Luo, Xiao‐Yuan Mao, et al.
Brain Research (2019) Vol. 1719, pp. 30-39
Closed Access | Times Cited: 18

Role of TRPV1/TRPV3 channels in olanzapine-induced metabolic alteration: Possible involvement in hypothalamic energy-sensing, appetite regulation, inflammation and mesolimbic pathway
Raghunath Singh, Yashika Bansal, Rupinder Kaur Sodhi, et al.
Toxicology and Applied Pharmacology (2020) Vol. 402, pp. 115124-115124
Closed Access | Times Cited: 16

Ameliorative effect of curcumin on olanzapine-induced obesity in Sprague-Dawley rats
Subramani Parasuraman, Khor Ming Zhen, Urmila Banik, et al.
Pharmacognosy Research (2017) Vol. 9, Iss. 3, pp. 247-247
Open Access | Times Cited: 18

Olanzapine-induced decreases of FGF21 in brown adipose tissue via histone modulations drive UCP1-dependent thermogenetic impairment
Xuemei Liu, Haotian Zhang, Shimei Zhang, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2022) Vol. 122, pp. 110692-110692
Closed Access | Times Cited: 9

The Obesity–Impulsivity Axis: Potential Metabolic Interventions in Chronic Psychiatric Patients
Adonis Sfera, Carolina Osorio, Luzmin Inderias, et al.
Frontiers in Psychiatry (2017) Vol. 8
Open Access | Times Cited: 16

Novel Tetrahydroquinazolinamines as Selective Histamine 3 Receptor Antagonists for the Treatment of Obesity
Ajeet Kumar, Venkata Reddy Pasam, Ravi Thakur, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 9, pp. 4638-4655
Closed Access | Times Cited: 15

Chronic betahistine co-treatment reverses olanzapine's effects on dopamine D2 but not 5-HT2A/2C bindings in rat brains
Jiamei Lian, Xu‐Feng Huang, Nagesh Pai, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2014) Vol. 56, pp. 75-80
Open Access | Times Cited: 14

Effect of safranal, a constituent of saffron, on olanzapine (an atypical antipsychotic) induced metabolic disorders in rat.
Sara Malekzadeh, Mahmoud Reza Heidari, Bibi Marjan Razavi, et al.
PubMed (2019) Vol. 22, Iss. 12, pp. 1476-1482
Closed Access | Times Cited: 14

Time-dependent effects of olanzapine treatment on the expression of histidine decarboxylase, H1 and H3 receptor in the rat brain: The roles in olanzapine-induced obesity
Meng Xiao He, Qingsheng Zhang, Chao Deng, et al.
Psychoneuroendocrinology (2017) Vol. 85, pp. 190-199
Closed Access | Times Cited: 14

Differential effects of short- and long-term antipsychotic treatment on the expression of neuregulin-1 and ErbB4 receptors in the rat brain
Chao Deng, Bo Pan, Changhua Hu, et al.
Psychiatry Research (2014) Vol. 225, Iss. 3, pp. 347-354
Closed Access | Times Cited: 13

Brain stem as a target site for the metabolic side effects of olanzapine
Imran J. Anwar, Kayoko Miyata, Andrea Zsombok
Journal of Neurophysiology (2015) Vol. 115, Iss. 3, pp. 1389-1398
Open Access | Times Cited: 13

Epigenetic Histone Methylation of PPARγ and CPT1A Signaling Contributes to Betahistine Preventing Olanzapine-Induced Dyslipidemia
Yueqing Su, Chao Deng, Xuemei Liu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9143-9143
Open Access | Times Cited: 4

Artesunate prevents rats from the clozapine-induced hepatic steatosis and elevation in plasma triglycerides
Yanmei Li, Ruibing Su, Shuqin Xu, et al.
Neuropsychiatric Disease and Treatment (2017) Vol. Volume 13, pp. 2477-2487
Open Access | Times Cited: 10

Early antipsychotic exposure affects NMDA and GABAA receptor binding in the brains of juvenile rats
Jiamei Lian, Chao Deng
Psychiatry Research (2019) Vol. 273, pp. 739-745
Closed Access | Times Cited: 10

Identification and characterization of proteins that are differentially expressed in adipose tissue of olanzapine-induced insulin resistance rat by iTRAQ quantitative proteomics
Ni Yang, Liangyu Yu, Yahui Deng, et al.
Journal of Proteomics (2019) Vol. 212, pp. 103570-103570
Closed Access | Times Cited: 10

Cevimeline co-treatment attenuates olanzapine-induced metabolic disorders via modulating hepatic M3 muscarinic receptor: AMPKα signalling pathway in female rats
Mei Han, Jiamei Lian, Yueqing Su, et al.
Journal of Psychopharmacology (2021) Vol. 36, Iss. 2, pp. 202-213
Closed Access | Times Cited: 8

The dosage-dependent effects of cevimeline in preventing olanzapine-induced metabolic side-effects in female rats
Jiamei Lian, Chao Deng
Pharmacology Biochemistry and Behavior (2020) Vol. 191, pp. 172878-172878
Closed Access | Times Cited: 8

Brown adipose tissue activity is modulated in olanzapine-treated young rats by simvastatin
Xuemei Liu, Xiyu Feng, Chao Deng, et al.
BMC Pharmacology and Toxicology (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 8

Dual-targeting Approach on Histamine H3 and Sigma-1 Receptor Ligands as Promising Pharmacological Tools in the Treatment of CNS-linked Disorders
Katarzyna Szczepańska, Kamil Kuder, Katarzyna Kieć‐Kononowicz
Current Medicinal Chemistry (2020) Vol. 28, Iss. 15, pp. 2974-2995
Closed Access | Times Cited: 8

Hypothesis: Amelioration of obesity‐induced cognitive dysfunction via a lorcaserin–betahistine combination treatment
Ike dela Peña, Johnny D. Figueroa, Wei‐Xing Shi
Pharmacology Research & Perspectives (2022) Vol. 10, Iss. 3
Open Access | Times Cited: 5

Gold nanoclusters eliminate obesity induced by antipsychotics
Meng Xiao He, Yao Jing, Zijun Zhang, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 4

Influence of betahistine repeated administration on a weight gain and selected metabolic parameters in the model of excessive eating in rats
Kamil Mika, Małgorzata Szafarz, Jacek Sapa, et al.
Biomedicine & Pharmacotherapy (2021) Vol. 141, pp. 111892-111892
Open Access | Times Cited: 5

Scroll to top